ProPublica

Journalism in the Public Interest

Cancel

Prescriber Checkup

At A Glance: This Prescriber in 2012

Physician Assistant, Medical

Self-Reported Primary Specialty

See Other Prescribers With This Specialty in This State »

6,771Medicare Part D Prescriptions Filled, Including Refills

Rank: 9 out of 141

$349K Total Retail Price of All Prescriptions

Rank: 18 out of 141

334 Patients Receiving at Least One Drug in Part D
57%Patients 65 Years and Older
76% Subsidized Claims for Low-Income Patients

How Does This Prescriber Compare to Peers?

In the same specialty and state. Caveats »

Drugs That Present Special Risks
Costs of Prescribing
Higher avg Average for
this specialty
in Tennessee
Lower avg

Schedule Two
Controlled Substances

6% of this provider’s 334 patients filled at least one prescription for a schedule two drug, compared to an average of 13%.

Schedule Three
Controlled Substances

20% of this provider’s 334 patients filled at least one prescription for a schedule three drug, compared to an average of 21%.

Risky Drugs to Seniors

2% of this provider’s 3,696 prescriptions for patients 65 and older were for "potentially dangerous" drugs, compared to an average of 1%.

Brand Name Drugs

24% of this provider’s prescriptions were for brand-name drugs, compared to an average of 18%.

Prescription Price

$52 was the average price of a prescription from this provider, compared to $59 among peers.

Prescriptions per Patient

20 is the average number of prescriptions (including refills) per patient, compared to an average of 9.


Another View

This chart shows a different comparison of all providers in this specialty based on their mix of drugs and volume. Providers are grouped by similarity; those least like their peers are farthest to the right. Hover over the bars to see names of other prescribers.

← Prescribers more like their peers Prescribers less like their peers →
KEY: How to read this
chart

Fewer Prescribers
More Prescribers

This Prescriber
Hover to see more prescribers

This Prescriber's Drugs

The table below list this provider’s drugs, the number of prescriptions and how many went to seniors. Drugs are ranked by volume and compared with the rank for all providers in the same specialty and state.

Click to Filter by Category

Clear Filter


S2

A schedule two drug. More » Schedule two drugs have a high potential for abuse and severe dependence, according to the Drug Enforcement Administration.

S3

A schedule three drug. More » Schedule three drugs have potential for abuse and dependence, according to the Drug Enforcement Administration.

A

An antipsychotic drug. More » Antipsychotics are frequently given to dementia patients, though it increases their risk of death.

R

A risky drug for seniors. More » The American Geriatrics Society has said this drug is "potentially dangerous" for seniors and might be inappropriate.

10

This provider is among the top 10 prescribers of
this drug in the country.

This provider’s prescriptions for this drug were for more days than those of peers. More » Because of this, his or her prescription count may be lower.

This provider’s prescriptions for this drug were for fewer days than those of peers. More » Because of this, his or her prescription count may be higher.

This Drug's Rank
Drug Name Total Prescriptions Filled
Including Refills
Prescriptions
to 65+
Category For this Prescriber For All Prescribers in
This Specialty in Tennessee
LISINOPRIL 233 161 1 2
HYDROCODONE-ACETAMINOPHEN 230 90 S3 2 1
SIMVASTATIN 227 159 3 3
OMEPRAZOLE 218 134 4 6
AMLODIPINE BESYLATE 185 121 5 11
TRAMADOL HCL 182 98 6 20
GABAPENTIN 174 61 7 5
METOPROLOL TARTRATE 167 103 8 12
FUROSEMIDE 152 66 9 10
LEVOTHYROXINE SODIUM 135 99 10 4
WARFARIN SODIUM 129 63 11 30
NEXIUM 118 40 12 21
METFORMIN HCL 108 70 13 7
PRAVASTATIN SODIUM 106 54 14 27
RANITIDINE HCL 96 46 15 22
LOVASTATIN 91 59 16 26
ALLOPURINOL 78 28 17 54
MELOXICAM 78 53 17 16
CITALOPRAM HBR 77 53 19 23
ENALAPRIL MALEATE 69 19 20 86
LOSARTAN-HYDROCHLOROTHIAZIDE 67 35 21 82
CRESTOR 66 43 22 35
TRIAMTERENE-HCTZ 65 48 23 79
DIGOXIN 63 17 24 88
POTASSIUM CHLORIDE 62 37 25 29
PANTOPRAZOLE SODIUM 60 35 26 55
METHOCARBAMOL 60 0 R 26 63
HYDROCHLOROTHIAZIDE 60 48 26 13
BUSPIRONE HCL 58 30 29 164
FENOFIBRATE 58 36 29 81
ZOLPIDEM TARTRATE 55 19 31 17
ATENOLOL 55 34 31 19
CLOPIDOGREL 54 26 33 39
AZITHROMYCIN 52 29 34 25
LISINOPRIL-HYDROCHLOROTHIAZIDE 51 19 35 28
About This Data

ProPublica obtained prescribing data from Medicare’s prescription drug benefit, known as Part D, under the Freedom of Information Act. The data for 2012 includes more than 1.2 billion prescriptions written by nearly 1.5 million doctors, nurses and other providers. This database lists about 382,000 of those providers who wrote 50 or more prescriptions for at least one drug that year. Almost three-fourths went to patients 65 and older; the rest were for disabled patients. Methodology »

Incorrect Info?

If you are a provider and you believe your address is incorrect, check the listing you created on the National Provider Identifier registry. If you change your listing, send a note to drugs@propublica.org and we will update your information. If you have other questions about this data, send a note to drugs@propublica.org.

Caveats
  • No comparisons are shown if 10 or fewer prescribers in the state share this specialty.
  • The list of top drugs includes only those for which this provider wrote 50 or more prescriptions, but all prescriptions are counted in the summary totals at the top.
  • The calculation of “Risky Drugs to Seniors” does not include drugs for which a provider wrote 11 or fewer prescriptions because Medicare redacted the information to protect patient privacy.
  • Comparisons do not take into account the medical conditions of patients. Medications for certain conditions do not have generic alternatives, so patients would receive more expensive brand name drugs.
  • This provider's address and specialty information was last updated on May 11, 2010.
  • Comparisons are based on each provider’s current address, not necessarily where he or she worked during the time period covered in this database.